Photo taken from ESTRO/X
Jul 6, 2024, 11:24
Insights from ESTRO24 on reirradiation in NSCLC by Jonas Willmann
European Society for Radiotherapy and Oncology shared on X:
“Insights from ESTRO24 on reirradiation in NSCLC and its impact on overall survival rates. Report on 2 studies, focusing on:
- optimal re-irradiation doses in NSCLC
- high-dose re-irradiation for lung cancer recurrences.“
Read further.
Source: European Society for Radiotherapy and Oncology/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 22:40
Dec 21, 2024, 22:37
Dec 21, 2024, 22:26
Dec 21, 2024, 19:39
Dec 21, 2024, 19:21
Dec 21, 2024, 19:19